BC3 Technologies is sharing more about bleeding preparedness throughout September.
Published
Signal category
Presence & Recognition
Quote
“Throughout September, we'll be sharing more about where bleeding preparedness fits into everyday emergency planning, and why access, education, and readiness matter.”
— BC3 Technologies team
Company
- Industry
- Biotechnology Research
- Location
- Baltimore, US
- Company size
- 8 employees
BC3 Technologies (BC3T, focus is on developing novel and effective antihemorrhagic products for the medical, military, and general consumer sectors. BC3T’s proprietary chitosan-based aerosol product allows ease of application on wounds as well high-clotting ability which rivals against competitors’ products in both performance and cost. The biggest differentiator for BC3T’s technology compared to others is that the chitosan-based product has maximized hemostatic activity, great stability, and wide-range of applications.
Founded 2018